Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & Administrative
Others
Ratios

AC Immune (ACIU) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for AC Immune (ACIU) over the last 11 years, with Q3 2025 value amounting to -$19.8 million.

  • AC Immune's Consolidated Net Income fell 41210.51% to -$19.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$84.6 million, marking a year-over-year decrease of 8960.07%. This contributed to the annual value of -$58.1 million for FY2024, which is 491.25% up from last year.
  • According to the latest figures from Q3 2025, AC Immune's Consolidated Net Income is -$19.8 million, which was down 41210.51% from -$25.6 million recorded in Q2 2025.
  • AC Immune's Consolidated Net Income's 5-year high stood at $6.4 million during Q3 2024, with a 5-year trough of -$25.6 million in Q2 2025.
  • Moreover, its 5-year median value for Consolidated Net Income was -$19.5 million (2022), whereas its average is -$17.8 million.
  • As far as peak fluctuations go, AC Immune's Consolidated Net Income surged by 13706.28% in 2024, and later tumbled by 41210.51% in 2025.
  • Over the past 5 years, AC Immune's Consolidated Net Income (Quarter) stood at -$23.1 million in 2021, then increased by 15.66% to -$19.5 million in 2022, then skyrocketed by 72.53% to -$5.3 million in 2023, then crashed by 237.25% to -$18.0 million in 2024, then fell by 9.95% to -$19.8 million in 2025.
  • Its Consolidated Net Income stands at -$19.8 million for Q3 2025, versus -$25.6 million for Q2 2025 and -$21.2 million for Q1 2025.